Prostate-Specific Antigen Screening and 15-Year Prostate Can

Prostate-Specific Antigen Screening and 15-Year Prostate Cancer Mortality

This secondary analysis of a randomized clinical trial assesses whether screening for prostate-specific antigen reduces prostate cancer mortality at

Related Keywords

United Kingdom , France , Stockholm , Sweden , Bristol , City Of , Cambridge , Cambridgeshire , Midlands , Leicestershire , Paris , France General , British , Swedish , Richardm Martin , Genevieve Hatton Brown , Chris Pawsey , Tom Steuart Feilding , Davey Smith , Public Health England National Cancer Registration , Bristol Biomedical Research Centre , Oxford Biomedical Research Centre , United Kingdom Office For National Statistics Census , Bristol Medical School , National Screening Council , National Health Services , Health Data Research United Kingdom , University Hospitals Bristol , Varian Medical Systems , United Kingdom Department Of Health , Oxford Cancer Research Centre , Office For National Statistics , United Kingdom Patient Information Advisory Group , Health Technology Assessment Programme , Cancer Research United Kingdom Programme Grant , Integrative Cancer Epidemiology Programme , Public Health Wales , United Kingdom National Institute For Health , Research Council , Young , Swedish National Board Of Health , Trial Group , Public Health England , Confidentiality Advisory Group , Care Research , Group Information , Analysis Service South West , United Kingdom National External Quality Assessment Service , European Association Of Urology , University Of Bristol , Department Of Population Health Sciences , National Disease Registration Service , Cancer Research United Kingdom , Bristol Trials Centre , Ge Healthcare , British Journal Of Urology International , Cluster Randomized Trial , Prostate Cancer , National Health Services Act , Consolidated Standards , Reporting Trials , United Kingdom Office , National Statistics Census , National Statistics , National Disease Registration , Public Health , Hoc Outcomes , Multiple Deprivation , Cancer Deaths , Cancer Grade , Hoc Results , European Randomized Study , Prostate Cancer Screening , Population Health Sciences , Drs Neal , Interest Disclosures , United Kingdom National Institute , Swedish National Board , Medical Research Council , Relation Therapeutics , British Journal , Urology International , United Kingdom Policy Advisory Board , Intuitive Surgical , Prostate Cancer United Kingdom , Cancer Research United , United Kingdom Department , Technology Assessment , Biomedical Research Centre , Surgical Innovation , Evaluation Theme , Surgical Interventional Trials Unit , Oxford Cancer Research , Drs Martin , Bristol Trials , European Association , Sharing Statement , Analysis Service ,

© 2025 Vimarsana